The effect of L-3,4-dihydroxyphenylalanine administration on glucose metabolism in brain.
D000284:Administration, Oral; D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002247:Carbon Isotopes; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism*; D005973:Glutamine / Q000378:metabolism; D005998:Glycine / Q000378:metabolism; D007274:Injections, Intraperitoneal; D007700:Kinetics; D007773:Lactates / Q000378:metabolism; D008297:Male; D051381:Rats; D012694:Serine / Q000378:metabolism; D013268:Stimulation, Chemical; D013654:Taurine / Q000378:metabolism; D013912:Threonine / Q000378:metabolism; D013997:Time Factors
D000596:Amino Acids; D001786:Blood Glucose; D002247:Carbon Isotopes; D007773:Lactates; D005973:Glutamine; D013654:Taurine; D013912:Threonine; D001224:Aspartic Acid; D012694:Serine; D004295:Dihydroxyphenylalanine; D005947:Glucose; D005998:Glycine